- Award from Professor Dame Sally Davies for NIHR Clinical Research Network Leading Commercial Prinicpal Investigators (2016)
- Uveitis Research Clinic - I lead a weekly uveitis research clinic, taking in referrals from the South-West region and promoting current clinical research trials at the Bristol Eye Hospital.
- Samsung Bioepis/SB11-G31-AMD - Chief Investigator
- GILEAD - Filgotiniib trial - PI
- Abbott Uveitis Study - Efficacy and Safety of Adalimumab in Subjects With Active /Inactive Uveitis (Visual I and II).
- COMO Study - A 12-month masked study comparing the safety and efficacy of ozurdex versus ranibizumab in branch retinal vein occlusion.
- TREND Study -PI
- CLARITY Study - PI
- LAEVO Study - PI
- Active involvement in all Bristol Eye Hospital clinical research trials including:
- RETAIN - Efficacy and safety of 0.5 mg ranibizumab in two “treat and extend” Treatment Algorithms vs. 0.5 mg ranibizumab as needed in patients with DME.
- MERLOT - Macular EpiRetinal Brachytherapy versus Lucentis only treatment.
- PATHOLOGICAL MYOPIA - Ranibizumab for the treatment of CNV secondary to pathological myopia.
- INFLAMMATORY CNVM – Ranibizumab treatment for inflammatory CNVM.
- NOVA22007 - A phase III, multicentre, randomised controlled, double-masked trial of NOVA22007 (Ciclosporin 0.1%) ophthalmic cationic emulsion versus vehicle in patients with moderate to severe dry eye syndrome.
- IVAN – Efficacy of monthly intravitreal Ranibizumab versus Bevacizumab in AMD.
- SAKURA – Safety and Efficacy of intravitreal Sirolimus in the treatment of active non-infectious posterior uveitis.
- VISUAL I / VISUAL II - Efficacy and Safety of Adalimumab in Subjects With Active /Inactive Uveitis.
- COMO - A 12-month masked study comparing the safety and efficacy of ozurdex versus ranibizumab in branch retinal vein occlusion.
- MATISSE – Dose escalation study and evaluation of PF-04523655 with/without Ranibizumab in DME.
Furthermore, I have personally helped to design a proforma to aid active recruitment into the uveitis clinical trials at the Bristol Eye Hospital.
Does glaucoma surgery alter the diurnal intraocular pressure profile ? –
Ross, A.H, Spry, P., Diamond, J.D & Sparrow, J.M. (2007)
The study is now complete and published in 2010.
I personally set up this study at the Bristol Eye Hospital, including all R&D and ethics applications, clinical recruitment and ensured that the results were published in the medical literature.
Ross, A.H, Singhal, P., Grey, R.H.B. & Mundasad, M. (2006) Analysis of medical factors associated with diabetic maculopathy in laser treated patients; long term follow up.
Lead role in research carried out in conjunction with department of Medicine and Ophthalmic surgery along with Dr Parag Singhal (Weston General Hospital) and Mr Rodney Grey.
- R.S. Khan, Ross, A.H, Galloway, P., Johnston, R. & Johnson, B. (2004) Hal, should I drive my car?
Assessment of a computerised classification of the Esterman driving visual field test.
Department of Ophthalmology, Cheltenham General Hospital and St. James University Hospital, Leeds.